Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
The study is a pilot, observational, retrospective, and (italian) multicenter study. The study will involve the collection of patient data from medical records for patients with Multicentric Castelman Disease Relapsed/Refractory who received treatment with at least one dose of siltuximab, as part of standard of care in a real-life context, from July 2016 till April 2022 in 31selected italian centres.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
65
Start Date
2023-03-01
Completion Date
2025-01
Last Updated
2024-12-06
Healthy Volunteers
No
Conditions
Locations (12)
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Bologna, Italy
Azienda Ospedaliera Sant'Anna e San Sebastiano
Caserta, Caserta, Italy
Policlinico di Bari - Azienda Ospedaliero Universitaria Consorziale Policlinico
Bari, Italy
Azienda Ospedaliera Universitaria Arcispedale Sant'Anna
Ferrara, Italy
Azienda Ospedaliero Universitaria Careggi
Florence, Italy
Irccs Ospedale San Raffaele
Milan, Italy
Azienda Ospedaliero-Universitaria "Maggiore della Carità"
Novara, Italy
Azienda Ospedaliera Di Padova
Padova, Italy
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy
Azienda Ospedaliera Universitaria Senese
Siena, Italy
Azienda ULSS 2 Marca Trevigiana - UOC Medicina Interna 1 Centro di Riferimento per le Malattie Rare del Sistema Immunitario e dell'Apparato Respiratorio
Treviso, Italy
Azienda Ulss 2 Marca Trevigiana- Ospedale Di Treviso
Treviso, Italy